The AB BIODISK name, company spirit and reputation are based on commitment to the highest standards of science. The company is perhaps best known for its dedication to antimicrobial resistance testing since the early 1950s. The mission left by its scientific founder, Hans Ericsson, Professor of Microbiology at the Karolinska Institute, “to Promote the Rational Use of Antibiotics” has been faithfully pursued for over 50 years.
AB BIODISK develops new product concepts and processes for manufacturing unique high quality diagnostic tests. The company's proprietary technology enables biochemical reagents to be accurately dispensed in picogram quantities in stable dry-chemistry formats. This innovative technique is used to produce antibiotic gradients for products like Etest®, System U3® and other forthcoming products.
Significant resources are dedicated to research and development and include in vitro studies of new antibiotics, antifungal and antimycobacterial agents. Susceptibility testing of fastidious and unusual organisms, detection of resistance mechanisms and epidemiologic investigations often involve collaborative work with laboratories throughout the world. This research exchange has opened up new product applications for testing of anaerobes, H. pylori, M. tuberculosis, M. avium-intracellulare, yeasts, moulds, mycoplasma and many other challenging organisms. Studies of enzymes conferring resistance e.g. ESBLs, metallo beta-lactamases, AmpC and other resistance mechanisms such as glycopeptide resistance in staphylococci and enterococci are on-going projects.
AB BIODISK is a privately held company with facilities for research and development, manufacturing and marketing situated in Solna, Sweden.
| Contact Details: |
| Dalvagen 10 |
| Solna |
| |
| 169 56 |
| Sweden |
| Tel: | 46-8-730 07 60 |
| Fax: | 46-8-83 81 58 |
| Email: | etest@abbiodisk.se |
| WWW: | www.abbiodisk.se/
|
| |
Recent Publications by AB BIODISK: |  |
Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.
Glycopeptide-intermediate Staphylococcus aureus (GISA) and, in particular,... | 25th September, 2009
|
| J Clin Microbiol. 2008 Sep;46(9):3042-7. Epub 2008 Jul 2.
DOI Direct Link |
Validation and reproducibility assessment of tigecycline MIC determinations by Etest.
A multicenter study was conducted to validate Etest tigecycline compared... | 7th November, 2007
| AB BIODISK, Solna, Sweden.
| J Clin Microbiol. 2007 Aug;45(8):2474-9. Epub 2007 May 23.
DOI Direct Link |
Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).
OBJECTIVE: To evaluate the in vitro spectrum and activity of linezolid, a... | 6th March, 2003
| AB BIODISK, Solna, Sweden, Buffalo Clinical Research Center, NY, USA.
| Clin Microbiol Infect. 2002 Dec;8(12):791-800.
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 2063 times since April 2007, the link to the organisation's website has been followed 240 times
Recent Search Terms used to find this page: bio disk | biodisk ab | biodisk | etest@abbiodisk.se | ab biodisk | AB Biodisk Dalv gen 10 169 56 Solna Sweden | company profile pdf jp | b od sk | AB-BIODISK | biodisk | .
Search for more companies in Solna
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
AB BIODISK
